Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
Published Online: 2023-07-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Andre P Fay•Arun A Azad•Cezary Szczylik•Curtis Dunshee•Cynthia G Healy•Daniel Heinrich•Eric Voog•Fabian Zohren•Jae Young Joung•Jan Oldenburg•Joan Carles•Karim Fizazi•Neal D Shore•Neeraj Agarwal•Nicola Di Santo•Nobuaki Matsubara•Peter C C Fong•Robert J Jones•Stefanie Zschäbitz•Ugo De Giorgi•Xun Lin
